Oncology Venture hereby publishes a prospectus regarding the rights issue starting on April 17, 2019

NEXT STORY
2019 Financial Calendar
PREV STORY
The Board of Oncology Venture resolves to conduct a rights issue of new shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surgical Care Affiliates Partners With River Valley Ambulatory Surgery Center

DEERFIELD, Ill., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”), ...

author_avatar
NASDAQ Market News

Leap Therapeutics Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

Roche’s Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people with PD-L1-positive metastatic triple-negative breast cancer

Tecentriq combination first immunotherapy regimen to demonstrate positive Phase III results in breast cancer ...

author_avatar
NASDAQ Market News